News|Articles|July 1, 2015
Biologics Development and Manufacturing Trends, Part 1
Eric Langer, Managing partner at BioPlan Associates, speaks with Pharmaceutical Technology about the results from the 12th annual BioPlan Associates survey, and single use technology adoption.
Advertisement
Eric Langer, Managing Partner at BioPlan Associates, spoke with Pharmaceutical Technology about the results from the 12th annual BioPlan Associates survey, and single use technology adoption.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
3
Challenges for the Global Manufacturing of Vaccines
4
Integrating Sustainability into the Core of Pharmaceutical Science
5
